{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:59:10Z","timestamp":1790060350729,"version":"4.0.1"},"reference-count":44,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/or.2014.3476","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T04:00:07Z","timestamp":1410753607000},"page":"2015-2022","source":"Crossref","is-referenced-by-count":19,"title":["Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells"],"prefix":"10.3892","volume":"32","author":[{"given":"BENQUAN","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QIAN","family":"ZOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MENG","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGFENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIANYANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONGHENG","family":"BAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZONGJING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BICHENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MENGTAO","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"key20180107210000_b1-or-32-05-2015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jso.20501","article-title":"Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma","volume":"93","author":"Akita","year":"2006","journal-title":"J Surg Oncol"},{"key":"key20180107210000_b2-or-32-05-2015","first-page":"313","article-title":"Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer","volume":"21","author":"Badiglian Filho","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107210000_b3-or-32-05-2015","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2002-02-0567","article-title":"The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines","volume":"100","author":"Batova","year":"2002","journal-title":"Blood"},{"key":"key20180107210000_b4-or-32-05-2015","doi-asserted-by":"crossref","first-page":"e27308","DOI":"10.1371\/journal.pone.0027308","article-title":"A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells","volume":"6","author":"Bordonaro","year":"2011","journal-title":"PLoS One"},{"key":"key20180107210000_b5-or-32-05-2015","first-page":"4325","article-title":"Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors","volume":"62","author":"Fournel","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107210000_b6-or-32-05-2015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2009.09.003","article-title":"Wnt signaling in development and disease","volume":"38","author":"Freese","year":"2010","journal-title":"Neurobiol Dis"},{"key":"key20180107210000_b7-or-32-05-2015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/156800909790192428","article-title":"Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery","volume":"9","author":"Ganesan","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107210000_b8-or-32-05-2015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107210000_b9-or-32-05-2015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/187152011795677391","article-title":"Combination therapy for the treatment of pancreatic cancer","volume":"11","author":"Greenhalf","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107210000_b10-or-32-05-2015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1593\/neo.121312","article-title":"WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer","volume":"15","author":"Griesmann","year":"2013","journal-title":"Neoplasia"},{"key":"key20180107210000_b11-or-32-05-2015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1479-5876-8-99","article-title":"MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status","volume":"8","author":"Grimm","year":"2010","journal-title":"J Transl Med"},{"key":"key20180107210000_b12-or-32-05-2015","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1158\/1078-0432.CCR-12-1327","article-title":"Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas","volume":"18","author":"Hidalgo","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107210000_b13-or-32-05-2015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbadis.2008.09.008","article-title":"Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells","volume":"1782","author":"Hong","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20180107210000_b14-or-32-05-2015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10637-010-9496-1","article-title":"YC-1, a novel potential anticancer agent, inhibits multidrug-resistant protein via cGMP-dependent pathway","volume":"29","author":"Hung","year":"2011","journal-title":"Invest New Drugs"},{"key":"key20180107210000_b15-or-32-05-2015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Mol Pharmacol"},{"key":"key20180107210000_b16-or-32-05-2015","first-page":"3505","article-title":"Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes","volume":"59","author":"Kornmann","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107210000_b17-or-32-05-2015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10799900050198372","article-title":"Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma","volume":"20","author":"Le","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"key20180107210000_b18-or-32-05-2015","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107210000_b19-or-32-05-2015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/sj.onc.1210769","article-title":"Deregulated Wnt\/beta-catenin program in high-risk neuroblastomas without MYCN amplification","volume":"27","author":"Liu","year":"2008","journal-title":"Oncogene"},{"key":"key20180107210000_b20-or-32-05-2015","first-page":"300","article-title":"Synergistic augmentation of cisplatin-induced apoptosis in HeLa cells by rapamycin","volume":"33","author":"Liu Yong","year":"2009","journal-title":"Central China Med J"},{"key":"key20180107210000_b21-or-32-05-2015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180107210000_b22-or-32-05-2015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14728222.2011.566216","article-title":"Overcoming drug resistance in pancreatic cancer","volume":"15","author":"Long","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107210000_b23-or-32-05-2015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1196\/annals.1414.024","article-title":"Surgical treatment of pancreatic cancer","volume":"1138","author":"Loos","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"key20180107210000_b24-or-32-05-2015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10456-005-5612-9","article-title":"Wnt\/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells","volume":"8","author":"Masckauchan","year":"2005","journal-title":"Angiogenesis"},{"key":"key20180107210000_b25-or-32-05-2015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","article-title":"Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance","volume":"46","author":"McCubrey","year":"2006","journal-title":"Adv Enzyme Regul"},{"key":"key20180107210000_b26-or-32-05-2015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000115967","article-title":"Resistance to chemotherapy in cancer: a complex and integrated cellular response","volume":"81","author":"Mellor","year":"2008","journal-title":"Pharmacology"},{"key":"key20180107210000_b27-or-32-05-2015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.clpt.6100296","article-title":"Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies","volume":"83","author":"Mimeault","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"key20180107210000_b28-or-32-05-2015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2010.02.015","article-title":"MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem\/progenitor cells and their progenies","volume":"295","author":"Mimeault","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107210000_b29-or-32-05-2015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamcr.2004.07.001","article-title":"Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells","volume":"1693","author":"Moore","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20180107210000_b30-or-32-05-2015","doi-asserted-by":"crossref","first-page":"38697","DOI":"10.1074\/jbc.M605293200","article-title":"A Mitogen-activated protein kinase mediates reactive oxygen species homeostasis in Arabidopsis","volume":"281","author":"Nakagami","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107210000_b31-or-32-05-2015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","article-title":"Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial","volume":"304","author":"Neoptolemos","year":"2010","journal-title":"JAMA"},{"key":"key20180107210000_b32-or-32-05-2015","doi-asserted-by":"crossref","first-page":"30950","DOI":"10.1074\/jbc.271.48.30950","article-title":"Role of the stress-activated\/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs","volume":"271","author":"Osborn","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107210000_b33-or-32-05-2015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1097-0215(20010520)95:3<194::AID-IJC1033>3.0.CO;2-M","article-title":"Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer","volume":"95","author":"Qiao","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107210000_b34-or-32-05-2015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.2000.2590","article-title":"The product of the ABC half-transporter gene ABCG2 (BCRP\/MXR\/ABCP) is expressed in the plasma membrane","volume":"271","author":"Rocchi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107210000_b35-or-32-05-2015","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.yexcr.2008.05.017","article-title":"O-GlcNAc-glycosylation of beta-catenin regulates its nuclear localization and transcriptional activity","volume":"314","author":"Sayat","year":"2008","journal-title":"Exp Cell Res"},{"key":"key20180107210000_b36-or-32-05-2015","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1245\/s10434-007-9583-5","article-title":"Development and characterization of gemcitabine-resistant pancreatic tumor cells","volume":"14","author":"Shah","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"key20180107210000_b37-or-32-05-2015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107210000_b38-or-32-05-2015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway","volume":"127","author":"Su","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107210000_b39-or-32-05-2015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/14728222.2011.607438","article-title":"Emerging pathways and future targets for the molecular therapy of pancreatic cancer","volume":"15","author":"Vaccaro","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107210000_b40-or-32-05-2015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","article-title":"Pericellular proteases in angiogenesis and vasculogenesis","volume":"26","author":"van Hinsbergh","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107210000_b41-or-32-05-2015","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/0008-5472.CAN-08-4312","article-title":"Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107210000_b42-or-32-05-2015","first-page":"1375","article-title":"Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells","volume":"23","author":"Yao","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107210000_b43-or-32-05-2015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.0912294107","article-title":"A beta-catenin\/TCF-coordinated chromatin loop at MYC integrates 5\u2032 and 3\u2032 Wnt responsive enhancers","volume":"107","author":"Yochum","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107210000_b44-or-32-05-2015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11605-010-1373-x","article-title":"Role of p53 and \u03b2-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma","volume":"15","author":"Yuan","year":"2011","journal-title":"J Gastrointest Surg"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3476\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:00:13Z","timestamp":1515340813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,9,10]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/or.2014.3476"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3476","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]}}}